Inflammatory bowel disease (IBD) continues to be one of the hottest topics at DDW®. This year, World IBD Day — Sunday, May 19 — falls during the meeting, giving AGA another reason to celebrate the best IBD research. See what programming is planned for the day and join AGA for a reception Sunday at 5:30 p.m. on the Center Terrace.
An AGA Postgraduate Course breakout session on ergonomics Saturday afternoon included tips for optimal room design and strategies to minimize musculoskeletal injury during endoscopy. The session was led by Katherine S. Garman, MD, AGAF, and Amandeep K. Shergill, MD, of the University of California, San Francisco School of Medicine.
A multidisciplinary panel will discuss current treatment options for benign solid and cystic liver masses, as well as the surgical and nonsurgical treatment options for hepatocellular carcinoma and cholangiocarcinoma during Monday morning’s AASLD symposium “The Management of Liver Masses,” co-chaired by Chirag Desai, MD.
Three difficult questions in clinical gastroenterology and hepatology are up for debate during Sunday’s “Battle of the Heavyweights: Controversies in Clinical Practice,” co-moderated by Joseph K. Lim, MD, AGAF.
Gareth Morris-Stiff, MD, PhD, will co-moderate Sunday’s “SSAT State-of-the-Art Conference: Advancements in the Microbiome.” The session will feature five expert lectures, including a presentation on “Colorectal/GI Optimization” by Benjamin Shogan, MD.
GI endoscopy never stands still. Neither can GI endoscopists, which is why ASGE brings its extended Postgraduate Course to DDW® every year, says course co-director Gregory G. Ginsberg, MD, FASGE. This year’s course — Best Practices and Emerging Paradigms — takes place on Sunday and Monday.
Functional gastrointestinal disorders have long been among the most common conditions diagnosed by gastroenterologists. A panel of three experts will discuss the current science and review best practices during Monday’s AGA Institute-Rome Foundation Lectureship, titled “Making Treatment Choices for Functional GI Disorders.”
During Sunday’s AASLD symposium “Role of Gut Microbiome in NAFLD and Progression of Fibrosis,” an expert panel of clinician-scientists will discuss recent research that is shedding light on the gut microbiome’s impact on hepatobiliary disease. Rohit Loomba, MD, shares more.
The gut microbiome is as much an organ as the liver, pancreas, intestine or any other organ along the GI tract, says Eugene B. Chang, MD, AGAF, who will moderate Monday’s AGA symposium “Microbiome Diagnostics, Prognostics and Personalized Medicine.”
Anne Marie Lennon, MD, PhD, FASGE, shares what GI innovation she finds the most promising, who inspired her to pursue a career in gastroenterology and more in this ASGE Speaker Spotlight.
